Enhancing rare disease trials: eCOA technology’s impact on s...
Sickle cell disease (SCD) affects an estimated 20 million people worldwide.
Ozempic patient blinded by NAION sues Novo Nordisk
Novo Nordisk has seen its first lawsuit over the proposed link between Ozempic and the rare eye disorder NAION.
Akeso PD-1 inhibitor cleared as Keytruda challenger advances
Akeso has bagged an FDA approval for its PD-1 inhibitor penpulimab and reported new data on highly-touted PD-1/VEGF bispecific ivonescimab.
AbbVie files fast-acting Botox successor in US
AbbVie is hoping to extend its range of neurotoxin-based pharma and cosmetic products with a short-acting successor to its blockbuster Botox brand.
Featured Content
Editor's Picks
Editor's Picks
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
4th In Vivo Cell Engineering & Gene Editing Summit
This forum brings together the brightest minds from biopharma, academia, and regulatory leadership to explore the full translational journey
6th Gene Therapy Analytical Development Summit Europe
Join 24+ expert speakers and over 90 industry stakeholders to unlock analytical strategies that elevate your development programmes,...
13th Tumor Models Summit Boston | July 22-23, 2025 | Boston,...
Improve preclinical tumor models to enhance translational oncology success.
6th RNA Editing Summit | July 29-31, 2025 | Advance RNA Edit...
The 6th RNA Editing Summit returns to Boston this July, bringing together 60+ experts to propel the next generation of RNA editing therapies
TPD & Induced Proximity Pharma Partnering Summit
Join the TPD & Induced Proximity Pharma Partnering Summit to accelerate partnership interest in your protein degradation pipeline or platform